INGN
Inogen Inc

1,466
Mkt Cap
$168.84M
Volume
41,423.00
52W High
$9.13
52W Low
$5.34
PE Ratio
-7.23
INGN Fundamentals
Price
$6.17
Prev Close
$6.20
Open
$6.16
50D MA
$6.15
Beta
1.23
Avg. Volume
346,861.19
EPS (Annual)
-$0.8551
P/B
0.88
Rev/Employee
$463,038.51
$75.37
Loading...
Loading...
News
all
press releases
CSM Advisors LLC Buys Shares of 364,100 Inogen, Inc $INGN
CSM Advisors LLC purchased a new position in Inogen, Inc (NASDAQ:INGN - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 364,100 shares of...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Inogen, Inc $INGN Shares Sold by Divisadero Street Capital Management LP
Divisadero Street Capital Management LP decreased its position in Inogen, Inc (NASDAQ:INGN - Free Report) by 80.6% during the 3rd quarter, according to the company in its most recent disclosure with...
MarketBeat·2d ago
News Placeholder
Short Interest in Inogen, Inc (NASDAQ:INGN) Expands By 24.2%
Inogen, Inc (NASDAQ:INGN - Get Free Report) was the target of a large growth in short interest in February. As of February 27th, there was short interest totaling 1,208,558 shares, a growth of 24.2...
MarketBeat·3d ago
News Placeholder
Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Kevin Smith, President and Chief Executive...
Business Wire·13d ago
News Placeholder
Inogen, Inc (NASDAQ:INGN) Short Interest Update
Inogen, Inc (NASDAQ:INGN - Get Free Report) was the recipient of a significant growth in short interest during the month of February. As of February 13th, there was short interest totaling 973,130...
MarketBeat·14d ago
News Placeholder
Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y
INGN posts narrower Q4 loss and 2% revenue rise, but shares dip as U.S. sales and rentals weaken despite international strength.
Zacks·21d ago
News Placeholder
Inogen Q4 Earnings Call Highlights
Inogen (NASDAQ:INGN) executives highlighted improving profitability, international momentum, and a broadened product portfolio during the company's fourth-quarter 2025 earnings call held February 24...
MarketBeat·21d ago
News Placeholder
Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates
Inogen (INGN) delivered earnings and revenue surprises of +27.78% and -0.34%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·22d ago
News Placeholder
Inogen (NASDAQ:INGN) Posts Earnings Results, Beats Expectations By $0.21 EPS
Inogen (NASDAQ:INGN - Get Free Report) announced its quarterly earnings data on Tuesday. The medical technology company reported ($0.15) earnings per share for the quarter, beating analysts...
MarketBeat·22d ago
News Placeholder
Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the...
Business Wire·22d ago
<
1
2
...
>

Latest INGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.